Outcomes for Recurrent Mantle Cell Lymphoma Post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database

por Rai, Shinya, Tanizawa, Yoshinori, Cai, Zhihong, Huang, Yu-Jing, Taipale, Kaisa, Tajimi, Masaomi
Publicado 2022

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France

por Taipale, Kaisa, Winfree, Katherine B, Boye, Mark, Basson, Mickael, Sleilaty, Ghassan, Eaton, James, Evans, Rachel, Chouaid, Christos
Publicado 2017

Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

por Molife, Cliff, Winfree, Katherine B., Bailey, Hollie, D’yachkova, Yulia, Forshaw, Cameron, Kim, Sangmi, Taipale, Kaisa-Leena, Puri, Tarun
Publicado 2023

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

por Asukai, Yumi, Valladares, Amparo, Camps, Carlos, Wood, Eifiona, Taipale, Kaisa, Arellano, Jorge, Cassinello, Alejo, Sacristán, José Antonio, Dilla, Tatiana
Publicado 2010

Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea

por Molife, Cliff, Cho, Jae Min, Lapthorn, Jennifer, Kang, Min Ju, D’yachkova, Yulia, Kim, Sangmi, Colman, Sam, Kim, Saerom, Szende, Agota, Park, Ji Hyun, Ahn, Hee Kyung, Hong, Min Hee, Taipale, Kaisa-Leena, Kim, Hye Ryun
Publicado 2022